Global Microbiology Testing Market (Clinical Microbiology Market) Size, Share, Trends, COVID-19 Impact & Growth Forecast Report – Segmented By Product, Application, Disease Area and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Industry Analysis (2024 to 2029)

Updated On: January, 2024
ID: 7136
Pages: 175

Global Microbiology Testing Market Size (2024 to 2029)

As per our report, the size of the global clinical microbiology market was worth USD 6.05 billion in 2024 and is projected to grow to USD 10.58 billion by 2029. The market is estimated to register a CAGR of 11.80% during the forecast period.

Microbiology testing, also known as Clinical microbiology, is a discipline that encompasses a broad range of testing methodologies for a diverse group of microorganisms. Clinical microbiology laboratories perform aerobic and anaerobic tests related to bacteriology, parasitology, mycobacteriology, and virology. According to the World Health Organization (WHO), HIV, malaria, tuberculosis (TB), and diseases like hepatitis and leishmaniosis together accounted for 4.3 million deaths worldwide. About 7 million people are affected by influenza in the U.S. itself; thus, there is a high demand for clinical microbiology as it helps to detect the infection much earlier. 

Global Microbiology Testing Market Drivers:

The growing incidence of infectious diseases and technological advancements are significant growth drivers to the global clinical microbiology market. There is an increasing awareness about the early detection of infection to avoid risk. It is boosting the microbiology testing market growth. The government and non-government organizations promote new technology in clinical microbiology as infectious diseases are increasing globally. Clinical microbiology uses many rapid tests to detect specific microbial antigens or nucleic acids in primary non-tissue specimens, which help identify the infection much quicker in serious conditions. It is propelling the market growth. There is an excellent advancement in the technology of clinical microbiology as it requires an accurate and reliable method to identify clinically significant microorganisms that are propelling the market growth. Over the last several years, many microbial laboratories have implemented automation to process isolation and detect a specific microorganism. 

Global Microbiology Testing Market Restraints:

Clinical microbiology requires well well-trained and skilled workforce as they need to handle pathogenic microorganisms. The equipment used in this test is high-cost and difficult to handle, which is estimated to hamper the growth of the global microbiology testing or clinical microbiology market. The rise in technical issues in real-time is also hindering the demand of the market. Strict rules by the government in approving new products are further expected to impede the market's growth.

Impact of COVID-19 on the global microbiology testing market:

The world has been placed on high alert due to the novel coronavirus (COVID-19) pandemic. The WHO declared a pandemic in the world in early March 2020. This pandemic has had a major impact on the clinical microbiology industry at an early stage. The industry is confronted with problems in the manufacturing and supply chain, such as the timely delivery of goods to end-users. Due to a shortage of qualified lab technicians to conduct diagnostic tests, limited support for research and development, and lockdowns, the supply of clinical microbiology products to end-users has been reduced. This pandemic forced the temporary closing of many research institutes across the world; due to this, the market was severely impacted during the early stages of the COVID-19 pandemic. Clinical microbiology is the study of microorganisms that cause infection in humans. According to the Centers for Disease Control and Prevention, the number of visits to physician offices with infectious and parasitic diseases as the primary diagnosis was 16 million in 2018. As a result of the outbreak of COVID-19, the demand for microbiology testing/clinical microbiology market has a positive growth rate.




Market Size Available

2023 to 2029

Base Year


Forecast Period

2024 to 2029

Segments Covered

By Product, Application, Disease Area, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis; DROC, PESTLE Analysis, Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leader Profiled

Danaher Corporation (U.S.), Becton, Dickinson, and Company (U.S.), Cepheid (U.S.) Abbott Laboratories Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), Alere Inc. (U.S.), Bruker Corporation (U.S.), and Hologic, Inc. (U.S.)


This research report on the global microbiology testing market has been segmented based on the product, application, disease area, and region.

Global Microbiology Testing Market - By Product:

  • Instruments           
  • Reagents 

Based on the product, the Instruments segment is expected to hold the largest share of the microbiology testing market over the analysis period. Factors such as the essential acquisition of conventional laboratory instruments amid end-users, advanced technologies in the area of molecular techniques & proteomics, and also the continuing trend of laboratory between clinical laboratories are boosting the market growth of the market.

Global Microbiology Testing Market - By Application:

  • Pharmaceutical     
  • Clinical       
  • Food Testing          
  • Energy      
  • Chemical and Material Manufacturing        
  • Environmental       

Based on the application, the clinical segment is considered to have the highest share of the microbiology testing market over the analysis period. A growing number of microbiology-based clinical trials and a rising number of clinical services worldwide greatly influence the demand of the market.

Global Microbiology Testing Market - By Disease Area:

  • Respiratory Diseases        
  • Bloodstream Infections     
  • Gastrointestinal Diseases 
  • Sexually Transmitted Diseases       
  • Urinary Tract Infections     
  • Periodontal Diseases          

Based on the Disease area, the respiratory diseases segment accounts for the highest share of the microbiology testing market. Factors like the increasing patient population suffering from respiratory diseases and the growing number of COVID-19 cases are surging the market's growth rate.

Global Microbiology Testing Market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

As of 2023, North America leads the market, accounting for a significant stake in the global market share. North America’s lead is warranted by the presence of key market players in the region, a relatively high number of registered treatments, and the increasing use of cartilage repair or regeneration to treat sports injuries and other accidents. Europe comes in second in terms of market share due to rising awareness about blood-related disorders and the swift availability of treatment in plasma fractionation.

However, Asia-Pacific is expected to outpace all other regions by clocking the highest CAGR during the forecast period, majorly because of the rising number of hospitals and clinical diagnostic laboratories in India and China; expanding research capabilities for the development of innovative and affordable clinical microbiology testing procedures across India, China, and Japan; and rising incidences of infectious diseases.


The major players in the global Microbiology Testing Market profiled in the report are Danaher Corporation (U.S.), Becton, Dickinson, and Company (U.S.), Cepheid (U.S.) Abbott Laboratories Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), Alere Inc. (U.S.), Bruker Corporation (U.S.), and Hologic, Inc. (U.S.), among others. The Global Microbiology Testing Market is quite consolidated, with the key companies spending a lot of money and time on R&D to expand market boundaries while also focusing on product differentiation. For Instance, In June 2020, Hoowaki LLC developed a one-piece injection-molded design for the COVID–19 swabs.

Please wait. . . . Your request is being processed

Frequently Asked Questions

What challenges does the microbiology testing market face?

Challenges include the need for skilled personnel, the time-consuming nature of traditional testing methods, and the constant evolution of microbial strains, which may require continuous updates to testing protocols.

How does the microbiology testing market contribute to public health?

Microbiology testing helps identify and control the spread of infectious diseases, ensures the safety of food and water supplies, and supports the development and quality assurance of pharmaceuticals, ultimately contributing to public health and safety.

How is the microbiology testing market regulated?

Regulations for microbiology testing vary by region and application. Organizations such as the FDA (Food and Drug Administration) in the United States and the European Medicines Agency (EMA) in Europe set standards and regulations for microbiology testing in their respective domains.

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample